Published in Drug Deliv Transl Res on August 01, 2015
Molecular mechanisms for enhanced DNA vaccine immunogenicity. Expert Rev Vaccines (2015) 0.79
Microneedles As a Delivery System for Gene Therapy. Front Pharmacol (2016) 0.78
Dissolving microneedles for DNA vaccination: Improving functionality via polymer characterisation and RALA complexation. Hum Vaccin Immunother (2016) 0.75
Ccl22 Diverts T Regulatory Cells and Controls the Growth of Melanoma. Cancer Res (2016) 0.75
Microneedle-mediated intradermal delivery of 5-aminolevulinic acid: potential for enhanced topical photodynamic therapy. J Control Release (2008) 1.65
Skin dendritic cell targeting via microneedle arrays laden with antigen-encapsulated poly-D,L-lactide-co-glycolide nanoparticles induces efficient antitumor and antiviral immune responses. ACS Nano (2013) 1.58
Hydrogel-Forming Microneedle Arrays for Enhanced Transdermal Drug Delivery. Adv Funct Mater (2012) 1.32
Recent advances in bacteriophage therapy: how delivery routes, formulation, concentration and timing influence the success of phage therapy. J Pharm Pharmacol (2011) 1.27
Laser-engineered dissolving microneedle arrays for transdermal macromolecular drug delivery. Pharm Res (2011) 1.21
Microneedles for intradermal and transdermal drug delivery. Eur J Pharm Sci (2013) 1.18
Influence of array interspacing on the force required for successful microneedle skin penetration: theoretical and practical approaches. J Pharm Sci (2013) 1.17
Hypoxia selects for androgen independent LNCaP cells with a more malignant geno- and phenotype. Int J Cancer (2008) 1.16
Effects of microneedle length, density, insertion time and multiple applications on human skin barrier function: assessments by transepidermal water loss. Toxicol In Vitro (2010) 1.10
Mucoadhesive drug delivery systems. J Pharm Bioallied Sci (2011) 1.07
Microneedle arrays permit enhanced intradermal delivery of a preformed photosensitizer. Photochem Photobiol (2008) 1.03
Anti-adherent and antifungal activities of surfactant-coated poly(ethylcyanoacrylate) nanoparticles. Int J Pharm (2007) 0.98
Influence of skin model on in vitro performance of drug-loaded soluble microneedle arrays. Int J Pharm (2012) 0.96
Dissolving polymeric microneedle arrays for electrically assisted transdermal drug delivery. J Control Release (2012) 0.96
Drug delivery strategies for photodynamic antimicrobial chemotherapy: from benchtop to clinical practice. J Photochem Photobiol B (2009) 0.95
Microneedle-mediated vaccine delivery: harnessing cutaneous immunobiology to improve efficacy. Expert Opin Drug Deliv (2012) 0.94
Gentamicin-loaded nanoparticles show improved antimicrobial effects towards Pseudomonas aeruginosa infection. Int J Nanomedicine (2012) 0.93
Cathepsin S from both tumor and tumor-associated cells promote cancer growth and neovascularization. Int J Cancer (2013) 0.93
Celecoxib-loaded poly(D,L-lactide-co-glycolide) nanoparticles prepared using a novel and controllable combination of diffusion and emulsification steps as part of the salting-out procedure. J Microencapsul (2006) 0.93
Physical characterisation and component release of poly(vinyl alcohol)-tetrahydroxyborate hydrogels and their applicability as potential topical drug delivery systems. Int J Pharm (2011) 0.93
Microporation techniques for enhanced delivery of therapeutic agents. Recent Pat Drug Deliv Formul (2010) 0.91
A novel FK506-like binding protein interacts with the glucocorticoid receptor and regulates steroid receptor signaling. Endocrinology (2008) 0.91
Designing photosensitizers for photodynamic therapy: strategies, challenges and promising developments. Future Med Chem (2009) 0.91
Photosensitiser delivery for photodynamic therapy. Part 2: systemic carrier platforms. Expert Opin Drug Deliv (2008) 0.91
Targeting treatment-resistant breast cancer stem cells with FKBPL and its peptide derivative, AD-01, via the CD44 pathway. Clin Cancer Res (2013) 0.90
Review of patents on microneedle applicators. Recent Pat Drug Deliv Formul (2011) 0.90
The emerging role of FK506-binding proteins as cancer biomarkers: a focus on FKBPL. Biochem Soc Trans (2011) 0.89
Electrically enhanced solute permeation across poly(ethylene glycol)-crosslinked poly(methyl vinyl ether-co-maleic acid) hydrogels: effect of hydrogel crosslink density and ionic conductivity. Int J Pharm (2011) 0.88
Investigation of solute permeation across hydrogels composed of poly(methyl vinyl ether-co-maleic acid) and poly(ethylene glycol). J Pharm Pharmacol (2010) 0.88
Synergistic phage-antibiotic combinations for the control of Escherichia coli biofilms in vitro. FEMS Immunol Med Microbiol (2012) 0.88
FKBPL and peptide derivatives: novel biological agents that inhibit angiogenesis by a CD44-dependent mechanism. Clin Cancer Res (2011) 0.88
Microneedle arrays as medical devices for enhanced transdermal drug delivery. Expert Rev Med Devices (2011) 0.87
The role of microneedles for drug and vaccine delivery. Expert Opin Drug Deliv (2014) 0.87
FKBPL regulates estrogen receptor signaling and determines response to endocrine therapy. Cancer Res (2010) 0.87
Laser-engineered dissolving microneedles for active transdermal delivery of nadroparin calcium. Eur J Pharm Biopharm (2012) 0.87
Nitric oxide synthase gene therapy enhances the toxicity of cisplatin in cancer cells. J Gene Med (2009) 0.87
Use of the radiation-inducible WAF1 promoter to drive iNOS gene therapy as a novel anti-cancer treatment. J Gene Med (2004) 0.86
Development of novel oral formulations prepared via hot melt extrusion for targeted delivery of photosensitizer to the colon. Photochem Photobiol (2011) 0.86
Microneedle mediated intradermal delivery of adjuvanted recombinant HIV-1 CN54gp140 effectively primes mucosal boost inoculations. J Control Release (2012) 0.85
Microneedle characterisation: the need for universal acceptance criteria and GMP specifications when moving towards commercialisation. Drug Deliv Transl Res (2015) 0.85
Effect of sub-lethal challenge with Photodynamic Antimicrobial Chemotherapy (PACT) on the antibiotic susceptibility of clinical bacterial isolates. J Photochem Photobiol B (2010) 0.85
Photodynamic Antimicrobial Chemotherapy (PACT) in combination with antibiotics for treatment of Burkholderia cepacia complex infection. J Photochem Photobiol B (2011) 0.85
Immunocolloidal targeting of the endocytotic siglec-7 receptor using peripheral attachment of siglec-7 antibodies to poly(lactide-co-glycolide) nanoparticles. Pharm Res (2007) 0.85
Enhanced antitumor activity of the photosensitizer meso-Tetra(N-methyl-4-pyridyl) porphine tetra tosylate through encapsulation in antibody-targeted chitosan/alginate nanoparticles. Biomacromolecules (2013) 0.84
Enhanced surface attachment of protein-type targeting ligands to poly(lactide-co-glycolide) nanoparticles using variable expression of polymeric acid functionality. J Biomed Mater Res A (2008) 0.84
Novel patch-based systems for the localised delivery of ALA-esters. J Photochem Photobiol B (2010) 0.84
Microneedle-mediated transdermal bacteriophage delivery. Eur J Pharm Sci (2012) 0.83
Evaluation of the penetration of 5-aminolevulinic acid through basal cell carcinoma: a pilot study. Exp Dermatol (2004) 0.83
Laser-engineered dissolving microneedle arrays for protein delivery: potential for enhanced intradermal vaccination. J Pharm Pharmacol (2014) 0.83
Modulation of gel formation and drug-release characteristics of lidocaine-loaded poly(vinyl alcohol)-tetraborate hydrogel systems using scavenger polyol sugars. Eur J Pharm Biopharm (2008) 0.83
Transcriptional regulation of inducible nitric oxide synthase gene therapy: targeting early stage and advanced prostate cancer. J Gene Med (2010) 0.82
Children's views on microneedle use as an alternative to blood sampling for patient monitoring. Int J Pharm Pract (2013) 0.82
Paediatricians' opinions of microneedle-mediated monitoring: a key stage in the translation of microneedle technology from laboratory into clinical practice. Drug Deliv Transl Res (2015) 0.82
Considerations in the sterile manufacture of polymeric microneedle arrays. Drug Deliv Transl Res (2015) 0.82
Design and evaluation of a water-soluble bioadhesive patch formulation for cutaneous delivery of 5-aminolevulinic acid to superficial neoplastic lesions. Eur J Pharm Sci (2005) 0.81
Strategies for enhanced peptide and protein delivery. Ther Deliv (2013) 0.81
Analysis of pyrazine 2,5-dipropionic acid in 5-aminolevulinic acid-loaded urological and topical delivery vehicles: methodology and assay validation. J Pharm Biomed Anal (2005) 0.80
Bioadhesive, non-drug-loaded nanoparticles as modulators of candidal adherence to buccal epithelial cells: a potentially novel prophylaxis for candidosis. Biomaterials (2004) 0.80
The anti-migratory effects of FKBPL and its peptide derivative, AD-01: regulation of CD44 and the cytoskeletal pathway. PLoS One (2013) 0.80
Systematic engineering of uniform, highly efficient, targeted and shielded viral-mimetic nanoparticles. Small (2013) 0.80
In vitro phototoxicity of 5-aminolevulinic acid and its methyl ester and the influence of barrier properties on their release from a bioadhesive patch. Eur J Pharm Biopharm (2006) 0.80
Conventional in vivo irradiation procedures are insufficient to accurately determine tumor responses to non-uniform radiation fields. Int J Radiat Biol (2014) 0.80
Dried blood spot assay for estimation of metronidazole concentrations in rats and its application in single animal drug pharmacokinetic study. J Chromatogr B Analyt Technol Biomed Life Sci (2011) 0.79
A cytochrome P450 2B6 meditated gene therapy strategy to enhance the effects of radiation or cyclophosphamide when combined with the bioreductive drug AQ4N. J Gene Med (2005) 0.79
The potential for human exposure, direct and indirect, to the suspected carcinogenic triphenylmethane dye Brilliant Green from green paper towels. Food Chem Toxicol (2011) 0.78
Comparison of a novel spray congealing procedure with emulsion-based methods for the micro-encapsulation of water-soluble drugs in low melting point triglycerides. J Microencapsul (2008) 0.77
Drug and light delivery strategies for photodynamic antimicrobial chemotherapy (PACT) of pulmonary pathogens: a pilot study. Photodiagnosis Photodyn Ther (2011) 0.77
Response of vulval lichen sclerosus and squamous hyperplasia to photodynamic treatment using sustained topical delivery of aminolevulinic acid from a novel bioadhesive patch system. Photodermatol Photoimmunol Photomed (2009) 0.77
Autoradiographic and scintillation analysis of 5-aminolevulinic acid permeation through epithelialised tissue: implications for topical photodynamic therapy of superficial gynaecological neoplasias. Pharm Res (2007) 0.77
Aminolaevulinic acid diffusion characteristics in 'in vitro' normal human skin and actinic keratosis: implications for topical photodynamic therapy. Photodermatol Photoimmunol Photomed (2008) 0.77
Evaluation of a water-soluble bioadhesive patch for photodynamic therapy of vulval lesions. Int J Pharm (2005) 0.77
Effect of microneedle treatment on the skin permeation of a nanoencapsulated dye. J Pharm Pharmacol (2012) 0.77
Flux of ionic dyes across microneedle-treated skin: effect of molecular characteristics. Int J Pharm (2012) 0.76
Electrically-responsive anti-adherent hydrogels for photodynamic antimicrobial chemotherapy. J Photochem Photobiol B (2012) 0.76
Hexyl aminolaevulinate is a more effective topical photosensitiser precursor than methyl aminolaevulinate and 5-aminolaevulinic acids when applied in equimolar doses. J Pharm Sci (2010) 0.76
Molecular investigations into vaginal immunization with HIV gp41 antigenic construct H4A in a quick release solid dosage form. Vaccine (2012) 0.75
Gamma irradiation and targeted radionuclides enhance the expression of the noradrenaline transporter transgene controlled by the radio-inducible p21(WAF1/CIP1) promoter. Radiat Res (2013) 0.75
Stability of 5-aminolevulinic acid in novel non-aqueous gel and patch-type systems intended for topical application. J Pharm Sci (2005) 0.75
Innovative drug delivery strategies for topical photodynamic therapy using porphyrin precursors. J Environ Pathol Toxicol Oncol (2007) 0.75
Preface. Recent Pat Drug Deliv Formul (2016) 0.75
Aminolevulinic acid-loaded Witepsol microparticles manufactured using a spray congealing procedure: implications for topical photodynamic therapy. J Pharm Pharmacol (2009) 0.75
Microneedle-mediated intrascleral delivery of in situ forming thermoresponsive implants for sustained ocular drug delivery. J Pharm Pharmacol (2013) 0.75
Influence of penetration enhancers on topical delivery of 5-aminolevulinic acid from bioadhesive patches. J Pharm Pharmacol (2010) 0.75
Formulation and characterization of poly(ethylene glycol)-based, 5-aminolevulinic acid-loaded solid-dosage forms intended for photodynamic and photodiagnostic methodologies in the colorectal region. J Environ Pathol Toxicol Oncol (2007) 0.75
Preaggregated Ag nanoparticles in dry swellable gel films for off-the-shelf surface-enhanced Raman spectroscopy. Anal Chem (2014) 0.75
Phototoxicity of 5-aminolevulinic acid in the HeLa cell line as an indicative measure of photodynamic effect after topical administration to gynecological lesions of intraepithelial form. Pharm Res (2004) 0.75
Novel bioadhesive patch-type system for photodynamic vulvodynia therapy after delivery of 5-aminolevulinic acid: preliminary evaluation. J Reprod Med (2007) 0.75